Merck PCSK9 Pill Results Point to Extremely Low Cholesterol Future – The New York Times

  1. Merck PCSK9 Pill Results Point to Extremely Low Cholesterol Future  The New York Times
  2. Experimental daily pill may lower cholesterol in patients who don’t see enough benefit with statins alone, study finds  CNN
  3. Merck’s pill to reduce cholesterol on top of statins matches results from injectables  statnews.com
  4. Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol  AJMC
  5. Investigational daily pill lowered bad cholesterol as much as injectables  www.heart.org

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *